» Articles » PMID: 37508933

Eleven Crucial Pesticides Appear to Regulate Key Genes That Link MPTP Mechanism to Cause Parkinson's Disease Through the Selective Degeneration of Dopamine Neurons

Overview
Journal Brain Sci
Publisher MDPI
Date 2023 Jul 29
PMID 37508933
Authors
Affiliations
Soon will be listed here.
Abstract

Pesticides kill neurons, but the mechanism leading to selective dopaminergic loss in Parkinson's disease (PD) is unknown. Understanding the pesticide's effect on dopaminergic neurons (DA) can help to screen and treat PD. The critical uptake of pesticides by the membrane receptors at DA is hypothesized to activate a signaling cascade and accelerate degeneration. Using MPTP as a reference, we demonstrate the mechanisms of eleven crucial pesticides through molecular docking, protein networks, regulatory pathways, and prioritization of key pesticide-regulating proteins. Participants were recruited and grouped into control and PD based on clinical characteristics as well as pesticide traces in their blood plasma. Then, qPCR was used to measure pesticide-associated gene expression in peripheral blood mononuclear cells between groups. As a result of molecular docking, all eleven pesticides and the MPTP showed high binding efficiency against 274 membrane receptor proteins of DA. Further, the protein interaction networks showed activation of multiple signaling cascades through these receptors. Subsequent analysis revealed 31 biological pathways shared by all 11pesticides and MPTP that were overrepresented by 46 crucial proteins. Among these, CTNNB1, NDUFS6, and CAV1 were prioritized to show a significant change in gene expression in pesticide-exposed PD which guides toward therapy.

Citing Articles

NIR-II light therapy improves cognitive performance in MPTP induced Parkinson's disease rat models: A preliminary experimental study.

Zhang J, Zhu Q, Shi X, Huang Y, Yan L, Zhang G Heliyon. 2024; 10(12):e32800.

PMID: 38975234 PMC: 11225833. DOI: 10.1016/j.heliyon.2024.e32800.


Niosomal Bupropion: Exploring Therapeutic Frontiers through Behavioral Profiling.

Harini K, Alomar S, Vajagathali M, Manoharadas S, Thirumalai A, Girigoswami K Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543152 PMC: 10976274. DOI: 10.3390/ph17030366.

References
1.
Chen M, Peng L, Gong P, Zheng X, Sun T, Zhang X . Baicalein Induces Mitochondrial Autophagy to Prevent Parkinson's Disease in Rats miR-30b and the SIRT1/AMPK/mTOR Pathway. Front Neurol. 2022; 12:646817. PMC: 8883053. DOI: 10.3389/fneur.2021.646817. View

2.
Kirubhanand C, Merciline Leonora J, Anitha S, Sangeetha R, Nachammai K, Langeswaran K . Targeting potential receptor molecules in non-small cell lung cancer (NSCLC) using in silico approaches. Front Mol Biosci. 2023; 10:1124563. PMC: 9947406. DOI: 10.3389/fmolb.2023.1124563. View

3.
Mayer B . Using systems biology to evaluate targets and mechanism of action of drugs for diabetes comorbidities. Diabetologia. 2016; 59(12):2503-2506. DOI: 10.1007/s00125-016-4032-2. View

4.
Tsai Y, Lein P . Mechanisms of organophosphate neurotoxicity. Curr Opin Toxicol. 2021; 26:49-60. PMC: 8302047. DOI: 10.1016/j.cotox.2021.04.002. View

5.
Oda W, Fujita Y, Baba K, Mochizuki H, Niwa H, Yamashita T . Inhibition of repulsive guidance molecule-a protects dopaminergic neurons in a mouse model of Parkinson's disease. Cell Death Dis. 2021; 12(2):181. PMC: 7884441. DOI: 10.1038/s41419-021-03469-2. View